Judith Mae Kramer, MD

Professor Emeritus of Medicine
Member in the Duke Clinical Research Institute
Campus mail 2400 Pratt St, Durham, NC 27705
Email address judith.kramer@duke.edu

· Studying methods to facilitate the uptake of evidence-based treatment recommendations.
· Optimizing the use of drugs, devices, and biological products in clinical practice.
· Studying methods of risk management for therapeutic products

Education and Training

  • M.D., University of North Carolina - Chapel Hill, 1977
  • M.S., University of North Carolina - Chapel Hill, 1972
  • B.S., University of North Carolina - Chapel Hill, 1970

Publications

Kramer, Judith M., L Kristin Newby, Wei Ching Chang, R John Simes, Frans Van de Werf, Christopher B. Granger, Kerry L. Lee, et al. “International variation in the use of evidence-based medicines for acute coronary syndromes.” Eur Heart J 24, no. 23 (December 2003): 2133–41. https://doi.org/10.1016/j.ehj.2003.09.018.

PMID
14643274
Full Text

Newby, L. K., M. V. Bhapkar, H. D. White, D. J. Moliterno, N. M. LaPointe, D. E. Kandzari, F. W. Verheugt, et al. “Aspirin use post-acute coronary syndromes: intolerance, bleeding and discontinuation.” Journal of Thrombosis and Thrombolysis 16, no. 3 (December 2003): 119–28.

PMID
15087598
Scholars@Duke

Allen LaPointe, N. M., A. Chen, B. Hammill, E. DeLong, J. M. Kramer, and R. M. Califf. “Evaluation of the dofetilide risk-management program.” American Heart Journal 146, no. 5 (November 2003): 894–901.

PMID
14597941
Scholars@Duke

LaPointe, Nancy M Allen, Carol A. Pamer, and Judith M. Kramer. “New antiarrhythmic agents for atrial fibrillation and atrial flutter: United States drug market response as an indicator of acceptance.” Pharmacotherapy 23, no. 10 (October 2003): 1316–21. https://doi.org/10.1592/phco.23.12.1316.32703.

PMID
14594348
Full Text

LaPointe, N. M., S. M. Al Khatib, J. M. Kramer, and R. M. Califf. “Knowledge deficits related to the QT interval could affect patient safety.” Annals of Noninvasive Electrocardiology : The Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 8, no. 2 (April 2003): 157–60.

PMID
12848798
Scholars@Duke

Al Khatib, S. M., N. M. LaPointe, L. H. Curtis, J. M. Kramer, J. Swann, P. Honig, and R. M. Califf. “Outpatient prescribing of antiarrhythmic drugs from 1995 to 2000.” The American Journal of Cardiology 91, no. 1 (January 2003): 91–94.

PMID
12505582
Scholars@Duke

Al Khatib, S. M., N. M. LaPointe, J. M. Kramer, and R. M. Califf. “What clinicians should know about the QT interval.” Jama : The Journal of the American Medical Association 289, no. 16 (2003): 2120–27.

PMID
12709470
Scholars@Duke

LaPointe, N. M., J. M. Kramer, K. P. Weinfurt, and R. M. Califf. “Practitioner acceptance of the dofetilide risk-management program.” Pharmacotherapy 22, no. 8 (August 2002): 1041–46.

PMID
12173789
Scholars@Duke

Pages